Rare disease clotting mystery probed in 57 patients

This study examined blood clotting in 57 people with Congenital Disorder of Glycosylation (CDG), a rare genetic condition. Researchers used a special test called the thrombin generation assay to see if the body's clotting system stays balanced despite having low levels of both clotting and anti-clotting proteins. The goal was to understand why some patients have bleeding or clotting problems, not to test a new treatment.